A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas

Author： Monga Varun   Swami Umang   Tanas Munir   Bossler Aaron   Mott Sarah L.   Smith Brian J.   Milhem Mohammed  

Publisher： MDPI

E-ISSN： 2072-6694|10|2|53-53

ISSN： 2072-6694

Source： Cancers, Vol.10, Iss.2, 2018-02, pp. : 53-53

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valproic Acid as a Potential Inhibitor of Plasmodium falciparum Histone Deacetylase 1 (PfHDAC1): An in Silico Approach

By Elbadawi Mohamed A. Abdallah   Awadalla Mohamed Khalid Alhaj   Abdel Hamid Muzamil Mahdi   Mohamed Magdi Awadalla   Awad Talal Ahmed  

International Journal of Molecular Sciences, Vol. 16, Iss. 2, 2015-02 ,pp. : 3915-3931

MDPI

Access to resources Recommend Favorite

The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells

By Cerna Tereza   Hrabeta Jan   Eckschlager Tomas   Frei Eva   Schmeiser Heinz H.   Arlt Volker M.   Stiborová Marie  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2018-01 ,pp. : 164-164

MDPI

Access to resources Recommend Favorite

Bevacizumab-Based Chemotherapy Combined with Regional Deep Capacitive Hyperthermia in Metastatic Cancer Patients: A Pilot Study

By Ranieri Girolamo   Ferrari Cristina   Di Palo Alessandra   Marech Ilaria   Porcelli Mariangela   Falagario Gianmarco   Ritrovato Fabiana   Ramunni Luigi   Fanelli Margherita   Rubini Giuseppe   Gadaleta Cosmo Damiano  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1458-1458

MDPI

Access to resources Recommend Favorite

Combination of Trabectedin and Gemcitabine for Advanced Soft Tissue Sarcomas: Results of a Phase I Dose Escalating Trial of the German Interdisciplinary Sarcoma Group (GISG)

By Kasper Bernd   Reichardt Peter   Pink Daniel   Sommer Michaela   Mathew Monika   Rauch Geraldine   Hohenberger Peter  

Marine Drugs, Vol. 13, Iss. 1, 2015-01 ,pp. : 379-388

MDPI

Access to resources Recommend Favorite

Dynamic Structure-Based Pharmacophore Model Development: A New and Effective Addition in the Histone Deacetylase 8 (HDAC8) Inhibitor Discovery

By Thangapandian Sundarapandian   John Shalini   Lee Yuno   Kim Songmi   Lee Keun Woo  

International Journal of Molecular Sciences, Vol. 12, Iss. 12, 2011-12 ,pp. : 9440-9462

MDPI

Access to resources Recommend Favorite